CurvaFix

CurvaFix, Inc. is a privately held medical device company, founded in 2013, that is addressing complex challenges in orthopedic trauma surgery. The company’s genesis stems from an idea by Dr. Robert Meek, a Clinical Professor Emeritus and the former Division Head of Orthopaedic Trauma at the University of British Columbia. Dr. Meek identified a critical unmet need for improved fixation methods for fractures in curved bones, particularly the pelvis, which existing straight screws and bone plates often inadequately address.

The company's core product is the CurvaFix® Intramedullary (IM) Implant, the first major innovation in pelvic trauma technology in three decades. This implant is uniquely designed to be flexible during a minimally invasive surgical procedure, allowing it to navigate the natural curvature of a patient's bone. Once correctly positioned over a steerable guidewire, the surgeon locks the implant, causing it to become rigid and provide strong, stable fixation. This approach is designed to fill the intramedullary space within the bone, distributing force more evenly and reducing the risk of implant pullout. The procedure can often be completed in as little as 20 to 25 minutes.

CurvaFix operates in the orthopedic trauma market, estimated to be over $1.1 billion globally, serving orthopedic trauma surgeons. Its clients are hospitals and surgical centers treating patients with pelvic fractures resulting from high-impact trauma (like car accidents) and fragility fractures common in geriatric patients. The company has received multiple 510(k) clearances from the U.S. Food and Drug Administration (FDA) for its devices, starting with the CurvaFix Rodscrew in 2019 and followed by clearances for its IM Implants. The implants are available in various diameters (7.5mm and 9.5mm) and lengths to accommodate different patient anatomies. To date, CurvaFix has raised approximately $60 million in funding over several rounds, including a significant $39 million Series C round in July 2023, led by MVM Partners. These funds are allocated to the nationwide commercial launch and expansion of its IM Implant system.

The company is headquartered in Bellevue, Washington. In July 2023, founder Steve Dimmer transitioned from CEO to a strategic advisory role, and Mark Foster, an executive with extensive experience in the medical device industry, including as former president and CEO of Trice Medical, was appointed as the new CEO.

Keywords: orthopedic trauma, pelvic fracture fixation, intramedullary implant, medical device, surgical technology, curved bone repair, minimally invasive surgery, fragility fractures, acetabular fractures, orthopedic surgery, bone fixation, trauma care, medical implant, CurvaFix IM Implant, Robert Meek, Steve Dimmer, Mark Foster, MVM Partners, Sectoral Asset Management, pelvic trauma.